Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
· financialcontent
AI Briefing
- • Regentis receives Japanese patent allowance for gelrinC technology.
- • The patent strengthens its global intellectual property portfolio.
- • The gelrinC technology expands protection in the world's largest cartilage repair market.
Context
Regentis has received a Japanese patent allowance. The patent expands intellectual property protection in Japan, one of the world's largest cartilage repair markets.
The patent allowance strengthens Regentis' global GelrinC intellectual property portfolio with new proprietary manufacturing technology.
Advertisement